Cargando…
RUNX2 and LAMC2: promising pancreatic cancer biomarkers identified by an integrative data mining of pancreatic adenocarcinoma tissues
Pancreatic carcinoma (PC) is a severe disease associated with high mortality. Although strategies for cancer therapy have made great progress, outcomes of pancreatic carcinoma patients remain extremely poor. Therefore, it is urgent to find novel biomarkers and therapeutic targets. To identify biomar...
Autores principales: | Jin, Guihua, Ruan, Qingqing, Shangguan, Fugen, Lan, Linhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544338/ https://www.ncbi.nlm.nih.gov/pubmed/34606473 http://dx.doi.org/10.18632/aging.203589 |
Ejemplares similares
-
ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis
por: Islam, Shajedul, et al.
Publicado: (2021) -
LAMC2 is a potential prognostic biomarker for cholangiocarcinoma
por: Ong, Khaa Hoo, et al.
Publicado: (2023) -
LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer
por: Cave, Donatella Delle, et al.
Publicado: (2022) -
S100A10 Promotes Pancreatic Ductal Adenocarcinoma Cells Proliferation, Migration and Adhesion through JNK/LAMB3-LAMC2 Axis
por: Lin, Hai, et al.
Publicado: (2022) -
Dimethyl Fumarate Induces Metabolic Crisie to Suppress Pancreatic Carcinoma
por: Chen, Kaiyuan, et al.
Publicado: (2021)